INmune Bio receives FDA fast track designation for alzheimer's drug

May 14, 2026 8:00 AM

INmune Bio Inc. (NASDAQ: INMB) announced the U.S. Food and Drug Administration has granted Fast Track designation to XPro1595 for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found